Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA563126
Max Phase: Preclinical
Molecular Formula: C63H119N25O12
Molecular Weight: 1418.81
Molecule Type: Protein
Associated Items:
ID: ALA563126
Max Phase: Preclinical
Molecular Formula: C63H119N25O12
Molecular Weight: 1418.81
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C)[C@@H](C)CC)C(C)C
Standard InChI: InChI=1S/C63H119N25O12/c1-13-34(9)46(57(98)82-41(23-18-28-77-63(72)73)52(93)84-44(32(5)6)56(97)79-37(12)49(90)80-39(48(65)89)21-16-26-75-61(68)69)87-55(96)43-24-19-29-88(43)59(100)45(33(7)8)85-58(99)47(35(10)14-2)86-53(94)40(22-17-27-76-62(70)71)81-50(91)36(11)78-54(95)42(30-31(3)4)83-51(92)38(64)20-15-25-74-60(66)67/h31-47H,13-30,64H2,1-12H3,(H2,65,89)(H,78,95)(H,79,97)(H,80,90)(H,81,91)(H,82,98)(H,83,92)(H,84,93)(H,85,99)(H,86,94)(H,87,96)(H4,66,67,74)(H4,68,69,75)(H4,70,71,76)(H4,72,73,77)/t34-,35-,36-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-,47-/m0/s1
Standard InChI Key: SZCGUFUTWDWPDP-CJMCYECYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1418.81 | Molecular Weight (Monoisotopic): 1417.9470 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Kindrachuk J, Paur N, Reiman C, Scruten E, Napper S.. (2007) The PhoQ-activating potential of antimicrobial peptides contributes to antimicrobial efficacy and is predictive of the induction of bacterial resistance., 51 (12): [PMID:17938183] [10.1128/aac.00854-07] |
2. Hilpert K, McLeod B, Yu J, Elliott MR, Rautenbach M, Ruden S, Bürck J, Muhle-Goll C, Ulrich AS, Keller S, Hancock RE.. (2010) Short cationic antimicrobial peptides interact with ATP., 54 (10): [PMID:20660668] [10.1128/aac.01664-09] |
Source(1):